Company · CIK 1659352
Codiak BioSciences, Inc.
| CIK | 1659352 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-11-19 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260781 | 2021-11-04 | 2022-09-14 | 4 | |
| 333-252888 | 2021-02-09 | 2021-02-12 | 3 | |
| 333-248692 | 2020-09-09 | 2020-10-14 | 4 | |
| 333-231100 | 2019-04-29 | 2019-07-01 | 2 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-09-14 | 424B5Shelf takedown | 333-260781 | 0001193125-22-243955 |
| 2022-09-12 | 424B5Shelf takedown | 333-260781 | 0001193125-22-242879 |
| 2021-11-15 | EFFECTDeclared effective | 333-260781 | 9999999995-21-004351 |
| 2021-11-04 | S-3Shelf registered | 333-260781 | 0001193125-21-320338 |
| 2021-02-12 | 424B4Final prospectus | 333-252888 | 0001193125-21-041423 |
| 2021-02-11 | EFFECTDeclared effective | 333-252888 | 9999999995-21-000622 |
| 2021-02-09 | S-1Registration filed | 333-252888 | 0001193125-21-034327 |
| 2020-12-29 | DRSDraft made public | 377-03967 | 0000950123-20-012926 |
| 2020-10-14 | 424B4Final prospectus | 333-248692 | 0001193125-20-269389 |
| 2020-10-13 | EFFECTDeclared effective | 333-248692 | 9999999995-20-002829 |
| 2020-10-07 | S-1/AAmendment | 333-248692 | 0001193125-20-265101 |
| 2020-09-09 | S-1Registration filed | 333-248692 | 0001193125-20-242253 |
| 2020-08-06 | DRSDraft made public | 377-03381 | 0000950123-20-007790 |
| 2019-07-01 | RWWithdrawn | 333-231100 | 0001193125-19-187107 |
| 2019-04-29 | S-1Registration filed | 333-231100 | 0001193125-19-125303 |
| 2019-03-06 | DRSDraft made public | 377-02534 | 0000950123-19-002593 |